Skip to main content Skip to navigation

シングルセル研究から得られる情報を最大限に活用

マルチオミクス技術により、1回の実験で各細胞のさまざまな情報を得ることができ、シングルセルの研究が将来にわたって有効なものとなりました。BDのソリューションを使用することで、より多くの情報を得られ、高品質なデータを収集し、さらに多くの発見が期待できます。1細胞あたり1セント未満のコストで実現できます

 

It's time to harness the power of more.
performance1

1つのソースで、より多くのOme

すべての細胞を見逃さず、DNA、RNA、タンパク質の情報をカバーして、各シングルセルについての洞察を最大化しましょう。

1細胞あたり1セント未満*

最小限のコストで、より多くの情報を収集しましょう。

 

シンプルで無料のデータ解析

複雑なデータを数回のクリックで簡単に役立つ情報に変えましょう。私たちの高次元データ解析ソフトウェアは、専門知識もコーディングも必要ありません。

唯一の完全なシングルセル マルチオミクスソリューション

高品質なデータ + ハイスループット + 数百万の細胞、すべてが1つのソリューションに

Complete BD Solutions

 

 

 

↓この表は削除します

 

Features**10x GenomicsBDParse Biosciences or Scale Biosciences
High capital expenditure
Yes 

No

N/A
Sample loss
Clogging and wetting failures

None

Poor retrieval due to multiple pipetting steps
Hands-on time
Moderate

Moderate

High
Multiomics assays offered by same vendor
DNA (Epigenomics), RNA

DNA (Epigenomics), RNA, Protein

RNA
Inter-user variability
Low, except for clogging and wetting failures

Low to none

Potentially high, due to multiple pipetting steps
Fragile samples and granulocytes
Poor

Good capture and recovery

Poor
Long-term stopping point during the workflow
<4 weeks

1 year after cell capture on beads

<6months
Partial use consumables
No

Yes

No
Multiplet rate
High

Moderate

Low

 

Generate

妥協のないシングルセル研究を

BD Rhapsody™ HT Xpressシステムは、高額な設備投資や96ウェルプレートへの長時間のピペッティングを不要にし、再現性のある高品質なデータを1細胞あたり1セント未満で提供します

 

マイクロウェルカートリッジベースのシステムは、数百万の細胞を研究するために必要なハイスループットを実現します。

 
Analyze
performance1

Analyze

シーケンシング後のデータからt-SNEプロットまで簡単に、無償で
 
  • コーディングもバイオインフォマティシャンも必要なく、私たちの無償のデータ解析ソフトウェアは、複雑なデータを簡単に解析し、理解しやすい形で結果を得ることをサポートします。追加のサポートが必要な場合は、専門家チームにアクセスできます。
  • BD Rhapsody™ Sequence Analysis Pipeline:わずか数クリックでシーケンシングの結果をマッピングし、実験のクオリティを確認するとともに、Visualization Toolで更なる解析を行うことができます。
  • BD® Cellismo Data Visualization Tool :2025年3月にリリースされた最新の二次解析ソフトウェアを無償でご利用いただけます。簡単な操作でデータをわかりやすい図表に変換し、生物学的に重要な洞察を得ましょう。
 
Analyze
performance1

最新ニュース

最新のeBookを読んで、シングルセル マルチオミクス、BD Rhapsody™ システム、およびセルソーティングが、がん免疫学の新しい発見や理解を深めるのにどのように役立つかをご確認ください。

eBookダウンロードはこちら
 
performance1
prev
next

The BD Rhapsody single-cell platform has been instrumental in advancing our translational research projects in inflammatory bowel disease (IBD) at Stanford. With the BD Rhapsody platform, we have been successful in robustly capturing traditionally difficult to isolate cell types (e.g. neutrophils) from intestinal biopsies. The platform has also enabled us to multiplex a large number of samples, capture significantly more cells, and perform advanced analyses combining whole transcriptomics with paired TCR and BCR sequencing.

The BD Rhapsody single-cell platform has been instrumental in advancing our translational research projects in inflammatory bowel disease (IBD) at Stanford. With the BD Rhapsody platform, we have been successful in robustly capturing traditionally difficult to isolate cell types (e.g. neutrophils) from intestinal biopsies. The platform has also enabled us to multiplex a large number of samples, capture significantly more cells, and perform advanced analyses combining whole transcriptomics with paired TCR and BCR sequencing.

John Gubatan, MD
Stanford University School of Medicine

The BD Rhapsody single-cell platform has been key for advancing our studies deciphering immunoregulatory networks in cancer and neglected diseases. We identified the cellular immune landscape using scarce human samples from tumors, lesions, and peripheral blood. We multiplexed four patient samples per cartridge using 10,000+ cells each to determine the activation state/functional potential of leukocytes in conjunction with their TCR or BCR variable region usage, thereby, allowing analysis of antigen specific responses with functional activity.

The BD Rhapsody single-cell platform has been key for advancing our studies deciphering immunoregulatory networks in cancer and neglected diseases. We identified the cellular immune landscape using scarce human samples from tumors, lesions, and peripheral blood. We multiplexed four patient samples per cartridge using 10,000+ cells each to determine the activation state/functional potential of leukocytes in conjunction with their TCR or BCR variable region usage, thereby, allowing analysis of antigen specific responses with functional activity.

Kenneth J. Gollob
Director
Center for Research Immuno-Oncology, São Paulo, Brazil

The BD Rhapsodysingle-cell platform has been a key tool for the publication of our clinical research. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. After the analysis, we got very interesting information about the changes in genes that were up or downregulated before and after the intervention. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsodysingle-cell platform.

The BD Rhapsodysingle-cell platform has been a key tool for the publication of our clinical research. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. After the analysis, we got very interesting information about the changes in genes that were up or downregulated before and after the intervention. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsodysingle-cell platform.

Olivia Yazmín Briceño Cárdenas, PhD
Researcher
Instituto Nacional de Enfermedades Respiratorias, Mexico City

We prefer the Rhapsodysystem for single cell RNA-Seq on our samples as it allows us to see what we have loaded before committing to expensive downstream analysis. The imaging is also indispensable for visualizing rare cancer cells in our liquid biopsy applications, as it provides insight even before characterizing the multiomic profile.

We prefer the Rhapsodysystem for single cell RNA-Seq on our samples as it allows us to see what we have loaded before committing to expensive downstream analysis. The imaging is also indispensable for visualizing rare cancer cells in our liquid biopsy applications, as it provides insight even before characterizing the multiomic profile.

Rob Salomon
Operations and Technical Manager, ACRF Child Cancer Liquid Biopsy Program
Children's Cancer Institute, Sydney

We as an early access user have adapted and rapidly expanded Rhapsodysingle cell multi-omics (WT, VDJ, AbSeq, and scATAC) services to a broad range of academic and industrial users. Our customers love BD Rhapsody 's super high capture capacity with multiplexing (SMK) approaches in the HT mode. It's robust, powerful, and cost-effective. The TCR/BCR Next works wonderfully as promised. The call rate of paired VDJ chains  is superior to almost all other single cell platforms.

We as an early access user have adapted and rapidly expanded Rhapsodysingle cell multi-omics (WT, VDJ, AbSeq, and scATAC) services to a broad range of academic and industrial users. Our customers love BD Rhapsody 's super high capture capacity with multiplexing (SMK) approaches in the HT mode. It's robust, powerful, and cost-effective. The TCR/BCR Next works wonderfully as promised. The call rate of paired VDJ chains  is superior to almost all other single cell platforms.

Xuhuai Ji
Lab Genomics Director
HIMC, Stanford University School of Medicine

The BD Rhapsody single-cell platform is an innovative device that lowers the threshold for single-cell transcriptomic research. It is highly effective in studying multiple samples simultaneously due to its multiplexing efficiency, utilizing various antibodies developed by BD over time. Additionally, since it does not use microfluidics for cell separation, it avoids clogging issues, making it suitable for studying cells from precious tissue samples.

The BD Rhapsody single-cell platform is an innovative device that lowers the threshold for single-cell transcriptomic research. It is highly effective in studying multiple samples simultaneously due to its multiplexing efficiency, utilizing various antibodies developed by BD over time. Additionally, since it does not use microfluidics for cell separation, it avoids clogging issues, making it suitable for studying cells from precious tissue samples.

TaeWoo Kwon
President/CEO
ROKIT Genomics, Seoul

The BD Rhapsody System has become one of our lab's most important single-cell analysis tools. Its precision, efficiency, and scalability have enabled us to uncover insights across a range of hematological cancers and healthy hematopoiesis at unprecedented resolution. It excels in its ability to generate high-quality single-cell proteo-genomics data of several hundreds of surface markers alongside transcriptomics data. Its intuitive design and high reproducibility has undoubtedly accelerated our research and opened up new avenues for discovery.

The BD Rhapsody System has become one of our lab's most important single-cell analysis tools. Its precision, efficiency, and scalability have enabled us to uncover insights across a range of hematological cancers and healthy hematopoiesis at unprecedented resolution. It excels in its ability to generate high-quality single-cell proteo-genomics data of several hundreds of surface markers alongside transcriptomics data. Its intuitive design and high reproducibility has undoubtedly accelerated our research and opened up new avenues for discovery.

Simon Haas, PhD
Berlin Institute of Health at Charité (BIH)
prev
next

Schedule a Meeting


Want to learn more about our solution? Contact us now to connect with our Multiomics Specialists.

 

 

*Required fields

*1細胞あたりセントの計算には機器と試薬が含まれますが、シーケンス コストは含まれません。米国の価格から計算されています。
performance1

  

  

研究用です。本製品は、疾病の診断・治療または予防に使用することはできません。